What Is Tumor Mutational Burden? The Food and Drug Administration approved an immunotherapy drug for tumors with high tumor mutational burden regardless of tumor type. But some medical oncologists say it’s not clear the biomarker is valid across all cancer types. by Anna Azvolinsky Survivor Profile An Unlikely Pivot Medha Deoras-Sutliff’s experience with breast cancer fueled her interest in advocacy for breast cancer patients and, more recently, her support for research on rare cancers. by Lindsey Konkel Survivor Profile Sharing Her Strength Diagnosed with two cancers prior to turning 40, Rebecca Esparza uses her voice to advocate for policy changes to help people affected by cancer. by Lindsey Konkel Advocacy in Action Leaving a Legacy Two mothers, each with a son who died of brain cancer, worked together to increase awareness and acceptance of tumor tissue donation. by Esther Landhuis A Unified Strategy A couple who lost their daughter to brain cancer builds a charity that connects parents, hospitals and researchers with data. by Marci A. Landsmann Finding More Targets for CAR-T Cells CAR-T cell therapy has successfully treated some patients with leukemia and lymphoma. Researchers are looking to expand the range of cancers that will respond to the therapy. by Kendall K. Morgan Survivor Profile Still in the Game ESPN reporter Holly Rowe worked through melanoma treatment. by Lindsey Konkel More Options for Rare Cancers Precision medicine and immunotherapy offer opportunities for new treatments and clinical trials to patients who previously had few, if any, options. by Kendall K. Morgan An Uncommon Partnership Through the Angiosarcoma Project, researchers are partnering with patients to learn about a rare cancer. by Ashley P. Taylor Learning to Share At first, I wanted to hide my cancer diagnosis. My son showed me what a mistake that was. by Lenn Robbins next Cancer Talk Exercise, Cancer and Aging A study on aging shows that cancer survivors are at higher risk of losing strength and walking more slowly compared to those with no cancer history. Exercise is one way to combat this decline by Marcus A. Banks Preconceived Notions: Cancer, Fertility Coverage and the Law Insurance coverage for fertility treatments is not mandated by federal law, although some states require it. People seeking cancer treatment need to understand their coverage and the law in their state. by Shelly Rosenfeld Drug Delays Recurrence in People With Early-Stage Breast Cancer People who have inherited BRCA mutations and are at high risk for cancer recurrence may benefit from a PARP inhibitor. by Pamela Rafalow Grossman Open Medical Records: Pros and Cons Patients now have full access to their online medical records. What are the benefits and downsides? by Jen Tota McGivney More Posts